WILLIAM L KUTCHER

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease NEW HYDE PARK, NY NPI 1487765889

General Payments — all program years on this page

$3,684.07

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 68
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,004.35 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,004.3515

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $363.2010
2019 $721.0714
2020 $190.815
2021 $507.448
2022 $330.417
2023 $566.799
2024 $1,004.3515

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078113378 Janssen Pharmaceuticals, Inc $125.00 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097321885 Novo Nordisk Inc $19.80 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097710800 Novo Nordisk Inc $15.64 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104692772 AstraZeneca Pharmaceuticals LP $122.82 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104752418 AstraZeneca Pharmaceuticals LP $125.00 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105558362 AstraZeneca Pharmaceuticals LP $125.00 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105880652 AstraZeneca Pharmaceuticals LP $13.51 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115840892 Amgen Inc. $13.23 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115840899 Amgen Inc. $15.09 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118030600 Boehringer Ingelheim Pharmaceuticals, Inc. $34.61 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118030602 Boehringer Ingelheim Pharmaceuticals, Inc. $111.29 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118030604 Boehringer Ingelheim Pharmaceuticals, Inc. $121.45 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118030606 Boehringer Ingelheim Pharmaceuticals, Inc. $123.86 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135484961 Lilly USA, LLC $16.27 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151811612 Chiesi USA, Inc. $21.78 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.